Liver Cancer News

Mount Sinai Performs First-in-the-World Liver Cancer Treatment Using More Flexible Scheduling Approach - Mount Sinai

Mount Sinai Performs First-in-the-World Liver Cancer Treatment Using More Flexible Scheduling Approach Mount Sinai

CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment - PharmaTimes

CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment PharmaTimes

New mouse model of virus-driven liver cancer may boost diagnosis and treatments - Medical Xpress

New mouse model of virus-driven liver cancer may boost diagnosis and treatments Medical Xpress

Interventional radiologist 1st in world to deliver newly approved cancer treatment - Radiology Business

Interventional radiologist 1st in world to deliver newly approved cancer treatment Radiology Business

Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial - AstraZeneca

Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial AstraZeneca

Pastor Lee’s Liver Cancer Vanishes After Diagnosis - 조선일보

Pastor Lee’s Liver Cancer Vanishes After Diagnosis 조선일보

Does solar jet lag contribute to liver cancer? - Fred Hutchinson Cancer Center

Does solar jet lag contribute to liver cancer? Fred Hutchinson Cancer Center

Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression - Fierce Pharma

Another AstraZeneca Emerald glimmers as Imfinzi, Imjudo delay liver cancer progression Fierce Pharma

EMERALD-3 Trial Shows Imfinzi-Based Combination Delays Liver Cancer Progression - Cure Today

EMERALD-3 Trial Shows Imfinzi-Based Combination Delays Liver Cancer Progression Cure Today

Unexplained shoulder pain could signal dangerous health condition, doctor warns - Fox News

Unexplained shoulder pain could signal dangerous health condition, doctor warns Fox News

AstraZeneca touts quadruplet approach in earlier-stage liver cancer - FirstWord Pharma

AstraZeneca touts quadruplet approach in earlier-stage liver cancer FirstWord Pharma

Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases - Genetic Engineering and Biotechnology News

Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases Genetic Engineering and Biotechnology News

AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial - Reuters

AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial Reuters

Y90-radioembolization radiation therapy for liver cancer patients - UT MD Anderson

Y90-radioembolization radiation therapy for liver cancer patients UT MD Anderson

Scientists target key protein duo driving colon, liver cancer - Medical Xpress

Scientists target key protein duo driving colon, liver cancer Medical Xpress

How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients - Rutgers University

How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients Rutgers University

IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer - Business Wire

IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer Business Wire

New grant funds research on circadian disruption and its potential link to liver cancer - Fred Hutchinson Cancer Center

New grant funds research on circadian disruption and its potential link to liver cancer Fred Hutchinson Cancer Center

Sim Kwon-ho Recovers from Liver Cancer, Confidently Jokes About Charm - 조선일보

Sim Kwon-ho Recovers from Liver Cancer, Confidently Jokes About Charm 조선일보

Hepatitis C and liver cancer: What to know - UT MD Anderson

Hepatitis C and liver cancer: What to know UT MD Anderson

Seeing This Doctor at Least Once a Year Lowered Liver Disease and Cancer Risk in a New Study - The Healthy

Seeing This Doctor at Least Once a Year Lowered Liver Disease and Cancer Risk in a New Study The Healthy

Five Things You May Not Know About Liver Cancer—from Managing Risks to Treating Disease - NYU Langone Health

Five Things You May Not Know About Liver Cancer—from Managing Risks to Treating Disease NYU Langone Health

AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial - Yahoo

AstraZeneca's liver cancer therapy combo slows disease progression in late-stage trial Yahoo

AstraZeneca's liver cancer breakthrough puts Imfinzi on course to become a super-blockbuster drug - Proactive Investors

AstraZeneca's liver cancer breakthrough puts Imfinzi on course to become a super-blockbuster drug Proactive Investors

MASLD and MASH: Fatty Liver Disease and Cancer Risk - American Cancer Society

MASLD and MASH: Fatty Liver Disease and Cancer Risk American Cancer Society

Boy, 2, Overcomes Cancer After Aunt Gives Him a ‘Second Chance’ with Liver Donation: ‘It Meant Everything’ - People.com

Boy, 2, Overcomes Cancer After Aunt Gives Him a ‘Second Chance’ with Liver Donation: ‘It Meant Everything’ People.com

Washington Post. . Crew Dearth, 2, is a liver cancer survivor whose “life was changed by a living donor,” according to the Cleveland Clinic. Crew walked down the hospital’s hallways to ring the Bravery Bell to celebrate the end of his cancer treatment. - facebook.com

Washington Post. . Crew Dearth, 2, is a liver cancer survivor whose “life was changed by a living donor,” according to the Cleveland Clinic. Crew walked down the hospital’s hallways to ring the Bravery Bell to celebrate the end of his cancer treatment. facebook.com

Novel Liver Cancer Vaccine Achieves Responses in Rare Disease Affecting Children and Young Adults - Johns Hopkins Medicine

Novel Liver Cancer Vaccine Achieves Responses in Rare Disease Affecting Children and Young Adults Johns Hopkins Medicine